ENTRY       K10166                      KO
NAME        TBX21
DEFINITION  T-box protein 21
PATHWAY     ko05321  Inflammatory bowel disease (IBD)
DISEASE     H01191  Asthma with nasal polyps and aspirin intolerance
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Human Diseases
              Immune diseases
               05321 Inflammatiory bowel disease (IBD)
                K10166  TBX21; T-box protein 21
            Transcription factors [BR:ko03000]
             Eukaryotic Type
              Other transcription factors
               T-box
                K10166  TBX21; T-box protein 21
GENES       HSA: 30009(TBX21)
            PTR: 749275(TBX21)
            PPS: 100976185(TBX21)
            GGO: 101151533(TBX21)
            PON: 100440593(TBX21)
            MCC: 694044(TBX21)
            MCF: 102141237(TBX21)
            MMU: 57765(Tbx21)
            RNO: 303496(Tbx21)
            CGE: 100762313(Tbx21)
            HGL: 101696563(Tbx21)
            TUP: 102503088(TBX21)
            CFA: 491044(TBX21)
            AML: 100480826
            FCA: 101097604(TBX21)
            PTG: 102957695(TBX21)
            BTA: 538933(TBX21)
            BOM: 102279363(TBX21)
            PHD: 102344924(TBX21)
            CHX: 102172385(TBX21)
            SSC: 100518804(TBX21)
            CFR: 102516916(TBX21)
            BACU: 103012498(TBX21)
            LVE: 103088493(TBX21)
            ECB: 100147606(TBX21)
            MYB: 102252074(TBX21)
            MYD: 102755039(TBX21)
            PALE: 102885141(TBX21)
            MDO: 100019545(TBX21)
            SHR: 100933226(TBX21)
            OAA: 100084162(TBX21)
            FAB: 101819278
            PHI: 102105779
            FPG: 101918734(TBX21)
            FCH: 102047291(TBX21)
            CLV: 102088747(TBX21)
            ASN: 102381641
            AMJ: 102561203
            CMY: 102942457(TBX21)
            ACS: 100558153
            PBI: 103049696(TBX21)
REFERENCE   PMID:24249581
  AUTHORS   Kovesdi D, Angyal A, Huber K, Szili D, Sarmay G
  TITLE     T-bet is a new synergistic meeting point for the BCR and TLR9 signaling cascades.
  JOURNAL   Eur J Immunol 44:887-93 (2014)
///
